|Year : 2021 | Volume
| Issue : 2 | Page : 59-65
Screening of phytocompounds, molecular docking studies, and in vivo anti-inflammatory activity of heartwood aqueous extract of Pterocarpus santalinus L.f.
C N Shanti Vasudevan1, Bibu John Kariyil2, D Athira Nair1, I'ma Neerakkal1
1 Department of Botany, Sacred Heart College, Thevara, Kochi 682013, Kerala, India
2 Department of Veterinary Pharmacology & Toxicology, College of Veterinary and Animal Sciences, Pookode 673576, Wayanad, Kerala, India
|Date of Submission||03-Jan-2020|
|Date of Decision||11-Feb-2020|
|Date of Acceptance||29-Jun-2020|
|Date of Web Publication||30-Dec-2020|
C N Shanti Vasudevan
Department of Botany, Sacred Heart College, Thevara, Kochi 682013, Kerala
Source of Support: None, Conflict of Interest: None
Objective: To evaluate the anti-inflammatory potential of aqueous extract of Pterocarpus santalinus L.f. heartwood using molecular docking and in vivo experiment.
Methods: An aqueous extract of Pterocarpus santalinus heartwood was prepared using a Soxhlet apparatus. Phytocompounds in the extract were tentatively identified using high-resolution mass spectrometry. Molecular docking experiments were carried out to evaluate the binding affinity of selected compounds, phloridzin to cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), prostaglandin E synthase-1 (PGES-1) and 5-lipoxygenase (5-LOX). Anti-inflammatory potential was evaluated by carageenan induced paw edema model in rats.
Results: The presence of major component phloridzin along with quercetin, parthenin, ginkgolide B, picrotoxinin, usnic acid, octopine, and epigallocatechin was detected in the extract. Molecular docking study showed that phloridzin inhibited COX-1, COX-2, PGES-1 and 5-LOX with more affinity than ibuprofen and paracetamol. Pterocarpus santalinus heartwood extract at 200 and 400 mg/kg BW showed significant reduction in carageenan-induced hind paw edema in a dose-dependent manner, but the effect was slow when compared with the standard ibuprofen (30 mg/kg p.o.).
Conclusions: The study indicated that after clinical trials, the aqueous extract of Pterocarpus santalinus heartwood can be effectively used in phytotherapy to treat inflammation.
Keywords: Phloridzin; COX-1; COX-2; PGES-1; 5-LOX
|How to cite this article:|
Vasudevan C N, Kariyil BJ, Nair D A, Neerakkal I. Screening of phytocompounds, molecular docking studies, and in vivo anti-inflammatory activity of heartwood aqueous extract of Pterocarpus santalinus L.f. Asian Pac J Trop Biomed 2021;11:59-65
|How to cite this URL:|
Vasudevan C N, Kariyil BJ, Nair D A, Neerakkal I. Screening of phytocompounds, molecular docking studies, and in vivo anti-inflammatory activity of heartwood aqueous extract of Pterocarpus santalinus L.f. Asian Pac J Trop Biomed [serial online] 2021 [cited 2021 Jan 19];11:59-65. Available from: https://www.apjtb.org/text.asp?2021/11/2/59/303604
| 1. Introduction|| |
The body produces inflammation as a defense mechanism to protect from harmful stimuli. It forms an important part of the body’s immune system. Pyrexia is produced as a result of various biochemical reactions in response to infectious or inflammatory stimuli. The most common anti-inflammatory and antipyretic drugs (NSAIDs) inhibit the cyclooxygenase enzymes isoforms cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) to varying degrees and thereby stop or decrease the formation of the principal fever mediator, PEG-2. COX inhibition can cause various health complications like gastrointestinal bleeding, nephrotoxicity, and cardiovascular side effects. Reye’s syndrome (liver damage) may be caused due to long term usage of ibuprofen. The strategy of third-generation NSAIDs includes development of dual cycloxygenase–lipoxygenase and prostaglandin synthase inhibitors.
Flavonoids show anti-inflammatory effects due to their potential for inhibiting proinflammatory enzymes like COX-1, COX-2, and 5-lipoxygenase (5-LOX). Several plants are used for treating inflammation and fever since ancient times. Hence investigating the anti-inflammatory and antipyretic potential of such plants can prove to be useful in finding natural substitutes for synthetic drugs with less toxicity and side effects.
Pterocarpus santalinus (P. santalinus) L.f. (Fabaceae), commonly known as ‘red sanders’, was listed as endangered by the IUCN but reclassified as near threatened. It is an endemic species to southeastern mountain range of South India. In the traditional system of Ayurvedic medicine, the decoction prepared from the heartwood of P. santalinus has various medicinal properties. Ayurvedic text Madanapala Nighantu suggests jwaraghna (antipyretic) property for the heartwood of P. santalinus. It is reported to have antipyretic, anti-inflammatory, antihelminthic, anti-hemorrhoidal, antidysenteric, aphrodisiac and diaphoretic activities.
Phytochemical studies on the bark of P. santalinus have identified the presence of isoflavone, isoflavone glucosides, aurone glycosides, lignans, yellow or orange pigments, and terpenoids. The heartwood contains isoflavone glucosides and two antitumour lignans, viz., savinin and calocedrin.
Little information is available on the phytochemical and pharmacological studies of aqueous extract of heartwood of P. santalinus. In this context, this study was aimed to identify the phytochemical components in the aqueous extract of P. santalinus heartwood by high-performance liquid chromatography-mass spectrometry (HPLC-MS) and to investigate the possible mechanism behind traditionally known anti-inflammatory and antipyretic action using molecular docking experiments. The binding affinity of the major component detected in the extract was evaluated with COX-1, COX-2, prostaglandin E synthase-1 (PGES-1) and 5-LOX. To validate the anti-inflammatory potential of the aqueous extract of P. santalinus heartwood, an in vivo experiment was carried out using carageenan-induced paw edema model in Wistar Albino male rats.
| 2. Materials and Methods|| |
2.1. Plant material collection and extraction
The heartwood samples of P. santalinus were collected, identified, authenticated, and submitted at Kerala Forest Research Institute, Peechi, Kerala (A voucher specimen - Accession No:16686). The plant sample was washed, dried under shade and ground to a fine powder in an electric blender. The aqueous extract was prepared in distilled water using a Soxhlet apparatus by continuous heat application. The extract was further concentrated in a rotary evaporator (Hanvapor HS-2005V, Hahnshin Scientific) and lyophilized.
2.2. HPLC-MS analysis of aqueous extract of P. santalinus heartwood
To identify the phytocomponents present in the aqueous extract of P. santalinus heartwood, high-resolution LC-Q-ToF-MS analysis was carried out at Sophisticated Analytical Instrument Facility, IIT Bombay, India. The analysis was performed using Agilent Technologies, USA, Model:1290 Infinity nano HPLC (Binary) with Chipcube (Microfluidic column), 6550 iFunnel Q-TOFs. The solvent system was used as follows: solvent A: water + 0.1% formic acid and solvent B: 90% acetonitrile + 10% water + 0.1% acetonitrile; a gradient started with 95% solvent A and ended with 100% solvent B. The flow rate was maintained at 0.3mL/min and injection volume was 5 μL. The column used was hypersil GOLD column (C18 100 mm × 2.1 mm, 3-micron). The sample was run in both positive and negative ionization modes from 140 m/z to 1 000 m/z. The analysis was performed using the following tuning parameters: gas temperature (250 °C), gas flow (13 L/min), nebulizer (35 psig), and nozzle voltage (1 000 V). Total LC running time was 30 min. The MS spectra of the analyzed sample was searched against the Metlin database to find the probable compounds present in the sample.
2.3. Molecular docking studies
Ibuprofen and paracetamol, widely used standards for inflammation and pyrexia respectively, were docked into the binding pockets of COX-1, COX-2, PGES-1 and 5-LOX. The most abundant compound with known anti-inflammatory and antipyretic effect in the aqueous extract of P. santalinus heartwood was also docked with the same enzymes to compare its binding affinity with the standards used. Molecular docking simulations were carried out using AutodockVina. Crystal structures of COX-1 (PDB ID 2OYE), COX-2 (PDB ID 3LN1), PGES-1 (PDB ID3DWW), and 5-LOX (PDB ID3V99) were obtained from PDB and the structures of ibuprofen, paracetamol and phloridzin were downloaded from PubChem database. The predicted docked poses of ibuprofen, paracetamol and phloridzin against COX-1, COX-2, PGES-1, and 5-LOX were analysed in Discovery studio visualizer.
2.4. In vivo experiment
The anti-inflammatory activity of the extract was tested using carageenan-induced rat paw edema model as described previously with slight modifications. A total of twenty-four Wistar Albino male rats weighing 100-200 g were used in this study. Rats were randomly divided into four groups of six rats each. Group I , Group II, Group III, and Group IV received distilled water (control), ibuprofen (30 mg/kg BW p.o.), 200 and 400 mg/kg BW p.o. of the aqueous extract of P. santalinus heartwood, respectively. After 1 h, 0.1 mL of 1% (w/v) carageenan was injected in the subplantar tissue of the right hind paw of each rat. The thickness of hind paw was measured at 1-hour interval for 4 h using vernier callipers. The percentage inhibition (PI) was calculated according to the below equation.
where To = mean paw thickness at 0 h; Tt = mean paw thickness at a particular time interval.
2.5. Statistical analysis
Measurements of paw thickness were expressed as mean ± standard error of the mean (SEM). Statistical analysis of results was performed by one-way analysis of variance (ANOVA) followed by multiple Tukey’s comparison tests. P<0.05 was considered statistically significant.
2.6. Ethical statement
The experiment was performed in accordance with the CPCSEA norms and approved by the Institute of Animal Ethical Committee of the College of Veterinary and Animal Sciences, Thrissur, Kerala, India where the study was conducted [Approval Order No. Acad (3)/6554/04 of Kerala Veterinary & Animal Science University, dated 27/09/18].
| 3. Results|| |
3.1. Secondary metabolites identified from the aqueous extract of P. santalinus heartwood
The compounds identified using HPLC-MS analysis are presented in [Table 1]. Phloridzin was detected both in positive and negative ionization mode. In negative ionization mode, compound 3, phloridzin, at retention time 4.775, showed the highest intensity [Figure 1]. Its MS spectra showed the molecular ion peak –ve ESI- m/z 435.128 and the fragment ions m/z 435, 190, 221, 315 [Figure 2].
|Figure 1: HRLC-ve ESI-MS-MS chromatogram of the aqueous extract of Pterocarpus santalinus heartwood.|
Click here to view
|Figure 2: MS/MS spectra and spectrum peak list of phloridzin (-ve ESI ) with m/z 435.128.|
Click here to view
|Table 1: Secondary metabolites identified from the aqueous extract of Pterocarpus santalinus heartwood and their retention time, m/z value and elemental composition.|
Click here to view
3.2. Molecular docking
Binding energy scores and amino acid interactions for ibuprofen, paracetamol, and phloridzin docked to COX-1, COX-2, PGES-1, and 5-LOX are shown in [Table 2]. Two-dimensional binding site interaction models are shown in [Figure 3]. Phloridzin had a higher affinity with COX-1, COX-2, PGES-1, and 5-LOX than the standard drugs ibuprofen and paracetamol. For phloridzin, the highest binding energy score of -8.7 kcal/mol was observed with COX-2. In addition, ibuprofen showed a better affinity with COX-1, COX-2, and PGES-1 than paracetamol.
|Figure 3: Two-dimensional binding site interaction models. (A) ibuprofen with COX-1; (B) paracetamol with COX-1; (C) phloridzin with COX-1; (D) ibuprofen with COX-2; (E) paracetamol with COX-2; (F) phloridzin with COX-2; (G) ibuprofen with PGES-1; (H) paracetamol with PGES-1; (I) phloridzin with PGES-1; (J) ibuprofen with 5-LOX; (K) paracetamol with 5-LOX; (L) phloridzin with 5-LOX. COX-1 and COX-2: cyclooxygenase-1 and 2, PGES-1: prostaglandin E synthase-1, 5-LOX: 5-lipoxygenase.|
Click here to view
|Table 2: Binding energy and amino acid interactions for ibuprofen, paracetamol, and phloridzin docked to selected targets.|
Click here to view
3.3. Anti-inflammatory activity
Anti-inflammatory effect of the aqueous extract of P. santalinus heartwood on carageenan-induced paw edema is presented in [Table 3]. The PI values obtained for the standard drug ibuprofen at a dose of 30 mg/kg BW from 1 h to 4 h were 45.5%, 68.5%, 82.4% and 91.8%, respectively. The PI values obtained for the aqueous extract of P. santalinus heartwood at the same time interval at doses of 200 and 400 mg/kg BW were 20.3%, 25.8%, 35.1%, 41.8% and 27.6%, 38.9%, 45.6%, 53.5%, respectively. Thus, the aqueous extract of P. santalinus heartwood at doses of 200 and 400 mg/kg BW inhibited paw edema in a dose-dependent manner. But the effect was slow when compared to the standard drug ibuprofen.
|Table 3: Effect of aqueous extract of Pterocarpus santalinus heartwood on carrageenan-induced paw edema in rats.|
Click here to view
| 4. Discussion|| |
In the present study, active constituents of the aqueous extract of P. santalinus heartwood were tentatively identified and the metabolite responsible for producing the anti-inflammatory and antipyretic effect was predicted. Flavonoids, terpenoid derivatives, phenolic compounds, and carotenoids prevailed among the extract. Quercetin tetramethyl (5, 7, 3’,4’) ether, epigallocatechin and 5,4’- dimethoxy-7-hydroxyflavone identified in the aqueous extract were in conformity with the earlier reports of similar compounds in the genus Pterocarpus,,. Among the compounds detected, phloridzin is reported to have anti-inflammatory and antipyretic activity. Phloridzin is a febrifuge like salicin. It was reported by De Koenick and Stass in the root bark of apple, pear, cherry and plum tree. Mode of action of phloridzin as an antimalarial agent is reported in vitro cultures of Plasmodium falciparum. Anti-inflammatory action of phloridzin by decreasing the synthesis of PGE2 and IL-8 is also reported.
Phloridzin possesses structural features that interact with COX-1, COX-2, PGES-1 and 5-LOX indicating that it can be a potent inhibitor of these enzymes. The presence of phloridzin in the aqueous extract of P. santalinus heartwood may be responsible for the antipyretic effect shown by the extract as reported in our previous in vivo study.
In vivo study indicated that the aqueous extract of P. santalinus heartwood showed a dose-dependent anti-inflammatory activity, but less effective than ibuprofen. The anti-inflammatory activity may be due to phloridzin content in the extract. Phloridzin showed more negative binding energy in silico, probably indicating the inhibition of COX-1, COX-2, and 5-LOX. Phloridzin showed more affinity with enzymes than the standards. However, the extract showed lower anti-inflammatory activity than the standards, which may be due to the synergistic effect of other compounds in the crude extract or lower concentration of phloridzin in the extract administered. The present molecular docking study supported the earlier reports of phloridzin being used against fever and inflammation. Its role in inhibiting cytokines responsible for inflammation process is also reported.
The study revealed the presence of several metabolites in the aqueous extract of P. santalinus heartwood. Molecular docking showed that phloridzin inhibits COX-1, COX-2, PGES-1 and 5-LOX with more affinity than ibuprofen and paracetamol. In vivo experiment proved anti-inflammatory effect of the extract. More studies, especially clinical trials, are needed to further confirm anti-inflammatory activity of the aqueous extract of P. santalinus heartwood.
Conflict of interest statement
The authors declare that there is no conflict of interest.
The corresponding author acknowledges UGC, Bangalore for granting Teacher Fellowship during the research work. Authors thank Sophisticated Analytical Instrument Facility, IIT Bombay for HRLCMS/MS service provided. The lab facility and animal house provided by the Dept. of Veterinary Pharmacology & Toxicology, College of Veterinary and Animal Sciences, Mannuthy, Thrissur, Kerala, India is duly acknowledged.
SVCN carried out the experiments and wrote the entire manuscript. BJK supervised the animal study experiment. AND carried out the molecular docking experiment. IN gave overall direction and helped in interpreting the results. All the authors provided critical feedback.
| References|| |
Huang MT, Ghai G, Ho CT. Inflammatory process and molecular targets for anti-inflammatory nutraceuticals. Compr Rev Food Sci Food Saf
Zampronio AR, Hoadley ME, Luheshi G, Rothwell NJ, de Souza GE, Hopkins SJ. Interleukin (IL)-6 release and fever induced by a pre-formed pyrogenic factor (PFPF) derived from LPS-stimulated macrophages. Eur Cytokine Netw
Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med
Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis
Hongo T, Momoki N, Mae S, Nozaki S, Takahashi K, Fujiwara T. A rare case of Reye’s syndrome induced by influenza A virus with use of ibuprofen in an adult. Acute Med Surg
Groesch S, Niederberger E, Geisslinger G. Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain. Expert Opin Invest Drugs
Hanakova Z, Hosek J, Kutil Z, Temml V, Landa P, Vanek T, et al. Antiinflammatory activity of natural geranylated flavonoids: Cyclooxygenase and lipoxygenase inhibitory properties and proteomic analysis. J Nat Prod
Gacche R, Shaikh R, Pund M, Deshmukh R. Cyclooxygenase inhibitory, cytotoxicity and free radical scavenging activities of selected medicinal plants used in Indian traditional medicine. Pharmacogn J
Chhetri DR. Medicinal plants used as antipyretic agents by the traditional healers of Daijeeling Himalayas. Indian J Tradit Know
Pullaiah T, Reddy VD. Pharmacology of red sanders. In: Pullaiah T, Balasubramanya S, Anuradha M (eds.) Red sanders: Silviculture and conservation
. Springer, Singapore; 2019, p. 57-76.
Arunakumara KK, Walpola BC, Subasinghe S, Yoon MH. Pterocarpus santalinus
Linn. f.(Rathhandun): A review of its botany, uses, phytochemistry and pharmacology. J Korean Soc Appl Biol Chem
Trott O, Olson AJ. AutoDockVina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem
Arpitha S, Srinivasan K, Sowbhagya HB. Anti-inflammatory effect of resin fraction of cardamom (Elettaria cardamomum)
in carrageenan- induced rat paw edema. Pharma Nutrition
Singh P, Bajpai V, Gupta A, Gaikwad AN, Maurya R, Kumar B. Identification and quantification of secondary metabolites of Pterocarpus marsupium
by LC-MS techniques and its in-vitro
lipid lowering activity. Ind Crops Prod
Sheehan EW, Zemaitis MA, Slatkin DJ, Schiff Jr PL. A constituent of Pterocarpus marsupium
, (-)-epicatechin, as a potential antidiabetic agent. J Nat Prod
Seshadri TR. Polyphenols of Pterocarpus
Chang WT, Huang WC, Liou CJ. Evaluation of the anti-inflammatory effects of phloretin and phlorizin in lipopolysaccharide-stimulated mouse macrophages. Food Chem
Gosch C, Halbwirth H, Stich K. Phloridzin: Biosynthesis, distribution and physiological relevance in plants. Phytochem
Graham T. Salicin and bodies obtained from its decomposition. In: Henry W (ed.) Elements of chemistry: Including the applications of the science in the arts
. Philadelphia: Lea & Blanchard; 1843, p. 595.
Kutner S, Breuer WV, Ginsburg H, Cabantchik ZI. On the mode of action of phlorizin as an antimalarial agent in in vitro
cultures of Plasmodium falciparum. Biochem Pharmacol
Zielinska D, Laparra-Llopis JM, Zielinski H, Szawara-Nowak D, Gimenez-Bastida JA. Role of apple phytochemicals, phloretin and phloridzin, in modulating processes related to intestinal inflammation. Nutrients
Shanti VCN, Bibu JK, I’ma N. Antipyretic activity of aqueous extract of heart wood of Pterocarpus santalinus
L. in yeast induced pyrexia. J Pharmacogn Phytochem
Milani R, Marcellini A, Montagner G, Baldisserotto A, Manfredini S, Gambari R, et al. Phloridzin derivatives inhibiting pro-inflammatory cytokine expression in human cystic fibrosis IB3-1 cells. Eur J Pharm Sci
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3]